[直接口服抗凝剂的过量服用]
Marie Anne-Catherine Neumann1, Noëlle Sieg1, Jorge Garcia Borrega1
1Klinik I für Innere Medizin, Centrum für integrierte Onkologie Aachen Bonn Köln Düsseldorf, Medizinische Fakultät und Uniklinik Köln, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Medizinische Klinik, Intensivmedizin und Notfallmedizin
|June 25, 2024
概括
直接口服抗凝剂 (DOAC) 的过量服用,通常是由于剂量或相互作用不正确,会增加死亡率. 及时诊断和特定的治疗方法,如逆转剂,对于有效管理DOAC过量剂量至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 血液学 血液学 血液学
背景情况:
- 直接口服抗凝剂 (DOAC) 广泛用于预防和治疗血栓栓塞事件.
- 不当剂量的DOAC治疗与患者死亡率的增加有关.
研究的目的:
- 提高对直接口服抗凝剂 (DOAC) 过量服用及其促成因素的认识.
- 概述用于管理DOAC过量使用的诊断和治疗策略.
主要方法:
- 一个案例介绍作为DOAC过量剂量的文献综述的基础.
- 治疗建议系统地从当前的科学文献中提取.
主要成果:
- 过量服用DOAC的原因包括故意/非故意摄入,对并发症或药物的错误剂量以及药物相互作用.
- 凝血测试应包括DOAC特定的测定以及全球测试.
- 治疗的指示包括严重出血或需要紧急手术.
- 治疗方案包括活性炭,药片检索,逆转药物 (伊达鲁齐祖马布,安德克萨内特阿尔法) 和因子替代.
结论:
- 为及时干预,教育临床医生对DOAC过量剂量的识别和管理至关重要.
- 本综述提供了有关诊断和治疗的最新见解,强调了进一步研究的必要性,以改进管理算法.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
517
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517
Anticholinesterase Agents: Poisoning and Treatment
845
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
845
Antidotes
626
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
626
Prevention of Further Absorption of Poison
816
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
816


